We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Beyond SpaceX: ETFs That Can Help to Tap the Growing Space Economy
Read MoreHide Full Article
Key Takeaways
Commercial space applications are expanding beyond traditional applications.
Morgan Stanley sees the space economy surpassing $1 trillion by 2040.
ETFs like UFO and ARKX offer diversified exposure to the growing space economy.
The excitement surrounding a potential SpaceX IPO has helped reignite investor interest in the space economy, but the investment opportunity extends far beyond it. The space economy is rapidly evolving into a broader industrial ecosystem with applications across multiple sectors.
Maintaining a long-term focus on the space economy could prove rewarding, as the sector's expanding commercial opportunities may create substantial value for investors willing to embrace this emerging frontier. Underscoring this trend is the performance of the S&P Kensho Space Index. The space index, which measures the performance of companies operating in the space sector, has added 106.2% over the past year and 45.7% so far this year.
According to CNBC, the increasing use of low Earth orbit by companies looking to explore microgravity environments to develop and manufacture medicines underscores how the space investment theme is evolving and increasingly reaching beyond launches, satellites and defense into new commercial sectors such as healthcare.
The growing commercialization of space is creating opportunities that extend well beyond traditional aerospace activities. As quoted on the abovementioned article, Morgan Stanley forecasts the sector could exceed $1 trillion by 2040, with industries like semiconductors, telecommunications and healthcare seeking to capitalize on the unique advantages of operating in space. Among these, healthcare appears particularly well-positioned to benefit in the near term.
Why is the Pharmaceutical Industry Turning to Space?
As per the CNBC article, pharmaceutical manufacturing on Earth is heavily influenced by gravity-induced effects such as sedimentation and convection, both of which can alter particle distribution and crystal formation during drug development.
Per Phil Williams, biophysics professor at the University of Nottingham, as quoted on the abovementioned article, without the disruptive effects of gravity, scientists can cultivate highly uniform crystals in space. These crystals are generally more predictable and exhibit fewer imperfections, making them particularly valuable for pharmaceutical applications. Williams also stated that higher molecular uniformity can lead to more reliable drug formulations, making treatments easier for patients to receive and use.
ETFs to Capture the Space Investment Boom
Increasing exposure to space-focused funds could offer meaningful long-term growth potential. Investors should adopt a long-term horizon to fully capitalize on this growth trajectory.
Below, we have highlighted a few funds that can help investors increase and diversify their exposure to the growing space economy.
With a one-month average trading volume of 9.67 million shares, ARKX is the most liquid option, ideal for active trading strategies. However, to fully benefit from the sector’s growth trajectory, a long-term investment approach is recommended.
NASA has gathered an asset base of $2.56 billion, the largest among the other options. In terms of annual fees, ROKT is the cheapest option, charging 0.45%, which makes it more suitable for long-term investing.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Shutterstock
Beyond SpaceX: ETFs That Can Help to Tap the Growing Space Economy
Key Takeaways
The excitement surrounding a potential SpaceX IPO has helped reignite investor interest in the space economy, but the investment opportunity extends far beyond it. The space economy is rapidly evolving into a broader industrial ecosystem with applications across multiple sectors.
Maintaining a long-term focus on the space economy could prove rewarding, as the sector's expanding commercial opportunities may create substantial value for investors willing to embrace this emerging frontier. Underscoring this trend is the performance of the S&P Kensho Space Index. The space index, which measures the performance of companies operating in the space sector, has added 106.2% over the past year and 45.7% so far this year.
According to CNBC, the increasing use of low Earth orbit by companies looking to explore microgravity environments to develop and manufacture medicines underscores how the space investment theme is evolving and increasingly reaching beyond launches, satellites and defense into new commercial sectors such as healthcare.
The growing commercialization of space is creating opportunities that extend well beyond traditional aerospace activities. As quoted on the abovementioned article, Morgan Stanley forecasts the sector could exceed $1 trillion by 2040, with industries like semiconductors, telecommunications and healthcare seeking to capitalize on the unique advantages of operating in space. Among these, healthcare appears particularly well-positioned to benefit in the near term.
Why is the Pharmaceutical Industry Turning to Space?
As per the CNBC article, pharmaceutical manufacturing on Earth is heavily influenced by gravity-induced effects such as sedimentation and convection, both of which can alter particle distribution and crystal formation during drug development.
Per Phil Williams, biophysics professor at the University of Nottingham, as quoted on the abovementioned article, without the disruptive effects of gravity, scientists can cultivate highly uniform crystals in space. These crystals are generally more predictable and exhibit fewer imperfections, making them particularly valuable for pharmaceutical applications. Williams also stated that higher molecular uniformity can lead to more reliable drug formulations, making treatments easier for patients to receive and use.
ETFs to Capture the Space Investment Boom
Increasing exposure to space-focused funds could offer meaningful long-term growth potential. Investors should adopt a long-term horizon to fully capitalize on this growth trajectory.
Below, we have highlighted a few funds that can help investors increase and diversify their exposure to the growing space economy.
Investors can consider Procure Space ETF (UFO - Free Report) , ARK Space & Defense Innovation ETF (ARKX - Free Report) , SPDR S&P Kensho Final Frontiers ETF (ROKT - Free Report) , Roundhill Space & Technology ETF (MARS - Free Report) , Global X Space Tech ETF (ORBX - Free Report) and Tema Space Innovators ETF (NASA - Free Report) .
With a one-month average trading volume of 9.67 million shares, ARKX is the most liquid option, ideal for active trading strategies. However, to fully benefit from the sector’s growth trajectory, a long-term investment approach is recommended.
NASA has gathered an asset base of $2.56 billion, the largest among the other options. In terms of annual fees, ROKT is the cheapest option, charging 0.45%, which makes it more suitable for long-term investing.